Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
Researchers are applying CRISPR-Cas9 as a stoichiometric binding tool to improve NGS library normalization. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results